Novel drug therapies – challenges and possibilities


09.00Registration and coffee/tea
09.30Welcome and introductionMargareta Hammarlund-Udenaes, Dean, Faculty of Pharmacy
09:45A 50 year-perspective: Disruptive changes in science, drug development and politicsUli Hacksell, Cerecor Inc., USA
Moderator: Karin Meyer, CEO Swedish Pharmaceutical Society
10:00The future of peptide drugs Jens Juul Holst, Department of Biomedical Sciences, Copenhagen University
10:30Precision oncology treatment – an increasing trend for a successful outcome Mef Nilbert, Department of Clinical Sciences, Lund University
11:00Creating a learning health care system with use of data basesStefan James, Uppsala Clinical Research Center (UCR), Uppsala University
11:30Lunch and poster session
13:30RD at Swedish Orphan BiovitrumMilan Zdravkovic, Head of R&D and Chief Medical Officer, Swedish Orphan Biovitrum
14:00From invention to clinical benefit – Do's and Don’tsAndreas Bhagwani, CEO Nanologica
14:30Debate: How can Sweden remain successful in developing important medicines in the 50 years to come? Moderator: Uli Hacksell, Cerecor Inc., USA

Tomas Salmonson, Swedish Medicinal Products Agency
Niklas Hedberg, Dental and Pharmaceutical Benefits Agency, (TLV)
Karin Meyer, Swedish Pharmaceutical Society
Margareta Hammarlund-Udenaes, Faculty of Pharmacy
Richard Bergström, SICPA, Switzerland
Andreas Bhagwani, Nanologica
Milan Zdravkovic, Swedish Orphan Biovitrum
15:20SummaryUli Hacksell, Cerecor Inc., USA
15:30Swedish Pharmaceutical Society 2018 honorary member award (Märit Johansson, chairman Swedish Pharmaceutical Society)
15:45ClosureMargareta Hammarlund-Udenaes, Dean, Faculty of Pharmacy